日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.

FGF21 药物治疗可显著改善血浆胆固醇代谢,从而减少动脉粥样硬化

Liu Cong, Schönke Milena, Zhou Enchen, Li Zhuang, Kooijman Sander, Boon Mariëtte R, Larsson Mikael, Wallenius Kristina, Dekker Niek, Barlind Louise, Peng Xiao-Rong, Wang Yanan, Rensen Patrick C N

A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding

长期高脂高胆固醇饮食喂养诱导的APOE*3Leiden.CETP小鼠表型异质性的系统分析

Paalvast, Yared; Zhou, Enchen; Rozendaal, Yvonne J W; Wang, Yanan; Gerding, Albert; van Dijk, Theo H; de Boer, Jan Freark; Rensen, Patrick C N; van Dijk, Ko Willems; Kuivenhoven, Jan A; Bakker, Barbara M; van Riel, Natal A W; Groen, Albert K

Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development

考来维仑可增强棕色脂肪激活对高脂血症和动脉粥样硬化发展的有益作用

Zhou, Enchen; Hoeke, Geerte; Li, Zhuang; Eibergen, Arthur C; Schonk, Amber W; Koehorst, Martijn; Boverhof, Renze; Havinga, Rick; Kuipers, Folkert; Coskun, Tamer; Boon, Mariëtte R; Groen, Albert K; Rensen, Patrick C N; Berbée, Jimmy F P; Wang, Yanan